Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2025

Feb 20, 2025

31799_dirs_2025-02-20_0e054176-7b97-42c1-b061-d9e57e9ad332.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2025-02-18

Reporting Person: Mara Joseph Anthony Jr (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-18 Common Stock M 4625 Acquired 19205 Direct
2025-02-18 Common Stock F 1450 $57.28 Disposed 17755 Direct
2025-02-18 Common Stock M 2754 Acquired 20509 Direct
2025-02-18 Common Stock F 809 $57.28 Disposed 19700 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-02-18 Restricted Stock Unit $ M 4625 Acquired Common Stock (4625) Direct
2025-02-18 Restricted Stock Unit $ M 2754 Acquired Common Stock (2754) Direct

Footnotes

F1: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest in annual installments on February 17, 2026, and February 17, 2027, respectively.

F2: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F3: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.

F4: The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest on February 18, 2026.

F5: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.

F6: No expiration date for this type of award.

F7: The Fair Market Value of the vested derivative securities is $57.28 per share.